Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 14,481 shares at $47.32 ($685K) on 2007-09-13, disclosed to the SEC on 2007-09-14.
Open-market sale of $685k MYGN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.22 | 479 | $23K | 3.3% |
| 2 | $47.22 | 750 | $35K | 5.2% |
| 3 | $47.23 | 600 | $28K | 4.1% |
| 4 | $47.24 | 1,000 | $47K | 6.9% |
| 5 | $47.25 | 300 | $14K | 2.1% |
| 6 | $47.27 | 1,100 |
| $52K |
| 7.6% |
| 7 | $47.28 | 400 | $19K | 2.8% |
| 8 | $47.29 | 300 | $14K | 2.1% |
| 9 | $47.30 | 50 | $2K | 0.3% |
| 10 | $47.30 | 1,550 | $73K | 10.7% |
| 11 | $47.31 | 1,900 | $90K | 13.1% |
| 12 | $47.32 | 3,375 | $160K | 23.3% |
| 13 | $47.33 | 1,100 | $52K | 7.6% |
| 14 | $47.34 | 1,200 | $57K | 8.3% |
| 15 | $47.35 | 377 | $18K | 2.6% |
| Total | $47.29 avg | 14,481 | $685K | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |